Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|139|10|2336-2342

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.139, Iss.10, 2016-11, pp. : 2336-2342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract